U.S. Fill-finish Pharmaceutical Contract Manufacturing Market Size & Outlook
U.S. fill-finish pharmaceutical contract manufacturing market, 2018-2030 (US$M)
Related Markets
U.S. fill-finish pharmaceutical contract manufacturing market highlights
- The U.S. fill-finish pharmaceutical contract manufacturing market generated a revenue of USD 5,531.0 million in 2024 and is expected to reach USD 8,584.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 7.5% from 2025 to 2030.
- In terms of segment, cartridges was the largest revenue generating segment in 2024.
- Vials is the most lucrative segment segment registering the fastest growth during the forecast period.
Fill-finish pharmaceutical contract manufacturing market data book summary
| Market revenue in 2024 | USD 5,531.0 million |
| Market revenue in 2030 | USD 8,584.4 million |
| Growth rate | 7.5% (CAGR from 2025 to 2030) |
| Largest segment | Cartridges |
| Fastest growing segment | Vials |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Vials, Prefilled Syringes, Cartridges |
| Key market players worldwide | Boehringer Ingelheim, Catalent Inc, Baxter International Inc, Eurofins Scientific SE, Recipharm, Fresenius SE & Co KGaA, Novartis AG ADR, Recro Pharma, Symbiosis Pharmaceutical Services, MabPlex International |
Other key industry trends
- In terms of revenue, U.S. accounted for 30.8% of the global fill-finish pharmaceutical contract manufacturing market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. fill-finish pharmaceutical contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 8,584.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Fill-finish Pharmaceutical Contract Manufacturing Market Scope
Fill-finish Pharmaceutical Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. fill-finish pharmaceutical contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fill-finish pharmaceutical contract manufacturing market will help companies and investors design strategic landscapes.
Cartridges was the largest segment with a revenue share of 26.22% in 2024. Horizon Databook has segmented the U.S. fill-finish pharmaceutical contract manufacturing market based on vials, prefilled syringes, cartridges covering the revenue growth of each sub-segment from 2018 to 2030.
The fill-and-finish pharmaceutical contract manufacturing market in the U.S. is highly competitive, with several key players operating in the region. Some major players are Catalent, Inc., AbbVie, Inc., Recipharm AB, Novartis, Lonza, Thermo Fisher Scientific, Inc., and Patheon.
The companies are expanding their product portfolios, R&D investments, and increasing their production capacity to maintain their strategic & competitive edge in the market.
Reasons to subscribe to U.S. fill-finish pharmaceutical contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. fill-finish pharmaceutical contract manufacturing market databook
-
Our clientele includes a mix of fill-finish pharmaceutical contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. fill-finish pharmaceutical contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. fill-finish pharmaceutical contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. fill-finish pharmaceutical contract manufacturing market size, by product type, 2018-2030 (US$M)
U.S. Fill-finish Pharmaceutical Contract Manufacturing Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
